The University of Ottawa trial infuses MSCs to reduce inflammation in the central nervous systems of MS patients.
The Multiple Sclerosis Society of Canada has funded Canada’s first stem cell clinical trial to treat multiple sclerosis, conducted by researchers at the University of Ottawa. The trial, called MESCAMS [Mesenchymal Stem Cell Therapy for Canadian MS patients], will comprise MSC infusions to the central nervous system to utilize their ability to regulate autoimmune attacks and reduce inflammation in 40 MS patients. Continue reading →
A new experimental therapy utilizes stem cells to treat cerebral palsy in children.
Due to the initial success of an experiment conducted by Duke University, doctors in Spain are now attempting a clinical trial in which stem cells are utilized to treat children with cerebral palsy. According to Dr. Luis Mader, the doctor performing the transplants, “Though this type of treatment is still in its very early stages, it is believed that regenerative therapies with stem cells could be a therapeutic option to regenerate the nerve tissue and repair brain damage.” Continue reading →
Saving stem cells in cord blood ensures access to emerging regenerative therapies.
As reported by the Wall Street Journal, adult stem cell therapies are advancing rapidly; with researchers utilizing stem cells to treat an expanding range of disease, trauma and injury. The article highlights the increasing use of cord blood to treat a variety of ailments such as; Cerebral Palsy, Traumatic Brain Injury and immune deficiencies such as diabetes. Continue reading →
In November 2008, a little boy suffered from cardiac arrest resulting in severe brain damage and a persistent vegetative state with his body paralyzed. These symptoms represent what is known as ‘infantile’ cerebral palsy, which has no known treatment. Despite the bleak prognosis, the boy’s parents found a way to drastically change their son’s life; through a transplant using his own stem cells that they chose to bank when he was born.